Cancer Risk of Angiotensin II Receptor Blocker Valsartan: A Population-based Study. Chan TH, Tsoi MF, Yung Cheung BM. J Cardiovasc Pharmacol 2022;79:577-582.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chan TH, Tsoi MF, Yung Cheung BM. Cancer Risk of Angiotensin II Receptor Blocker Valsartan: A Population-based Study. J Cardiovasc Pharmacol 2022;79:577-582.
PMID: 35020688